Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has repurchased a total of 234,542 ordinary shares on the London Stock Exchange between April 13 and April 17, 2026, as part of its $250 million share repurchase program. The volume-weighted average price paid per share during this period ranged from 1,307.00 pence to 1,354.24 pence. Cumulatively, since the program's inception on February 26, 2026, Hikma has bought back 4,374,095 shares for £54.8 million. Following these transactions, the company holds 12,833,233 shares in treasury, with 217,512,358 ordinary shares currently in issue.

Disclaimer*

UK 100

Latest directors dealings